Among other important results will be those by Aurobindo Pharma, Chemcon Speciality Chemicals, Sai Silks (Kalamandir), Mawana Sugars, MM Forgings and Yatharth Hospital & Trauma Care Services.
On Friday, over 350 companies announced their December quarter earnings, which included Hero MotoCorp, Mamaerath’s parent Honasa Consumer and Tata Power.
Here's what to expect from Divi’s Laboratories and ONGC results:
Divi’s Laboratories Ltd is expected to report a strong double-digit year-on-year (YoY) growth in earnings for the quarter ended December, aided by a favourable base and stable raw material costs. The consolidated net profit for the quarter is seen rising 33% YoY to Rs 407.40 crore, according to the average of estimates given by five brokerage firms.
Revenue is likely to grow by 17% YoY to Rs 1,994.20 crore, and operating profit, calculated as earnings before interest, taxes, depreciation and amortisation or EBITDA, is seen increasing by 38% to Rs 562 crore, the estimates showed.
Read more: Divi’s Labs Q3 preview: PAT may grow 33% YoY on favourable base; outlook eyed
Leading oil and gas player ONGC is expected to report subdued, but steady numbers for the third quarter ended December 2023 on the back of weak crude and gas price realisations. Net profit for the third quarter is likely to fall around 13% year-on-year (YoY), according to an average estimate of four brokerages. On a sequential basis, profit is seen dropping by a marginal 1%.
Revenue from